Condition
SAH
Total Trials
7
Recruiting
1
Active
1
Completed
5
Success Rate
83.3%-3% vs avg
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
14.3%
1 terminated out of 7 trials
Success Rate
83.3%
-3.2% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
83% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
Early P 1 (1)
P 1 (1)
Trial Status
Completed5
Terminated1
Recruiting1
Trial Success Rate
83.3%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT03754725Phase 1RecruitingPrimary
Ferritin and Iron Burden in SAH sIRB
NCT04988932Not ApplicableCompletedPrimary
Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm
NCT01832389Not ApplicableCompleted
Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage
NCT01656317Not ApplicableCompletedPrimary
Rehabilitation of Patients After Subarachnoid Hemorrhage
NCT01343537Early Phase 1Terminated
Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Subjects
NCT01569100CompletedPrimary
Atorvastatin After Aneurysmal Subarachnoid Hemorrhage
NCT01556620Completed
Is NIRS Able to Detect Ischemia Following Brain Insult
Showing all 7 trials